|
|
| m Im/08 / Provecs Medical (0 Trials) |
|
| m Im01 / Provecs Medical (0 Trials) |
|
| M-3258 / EMD Serono (0 Trials) |
|
| M-400 / Debiopharm (0 Trials) |
|
| m-ceNK cells / ImmunityBio (0 Trials) |
|
| M-Vax (DNP VACC) / AVAX Technologies (0 Trials) |
|
| M012 / Merganser (0 Trials) |
|
| M032 / The University of Alabama (0 Trials) |
|
| M102 / Aclipse Therap, The University of Sheffield (0 Trials) |
|
| M106 / Aclipse Therap, The University of Sheffield (0 Trials) |
|
| M1069 / EMD Serono, Domain Therap (0 Trials) |
|
| M108 / FutureGen Biopharmaceutical (0 Trials) |
|
| M118103 / Maruho (0 Trials) |
|
| M1231 / EMD Serono (0 Trials) |
|
| M131 / FutureGen Biopharmaceutical (0 Trials) |
|
| M1E4 / Stainwei Biotech (0 Trials) |
|
| M201-A / AETAS Pharma (0 Trials) |
|
| M23 / Stainwei Biotech (0 Trials) |
|
| M254 / J&J (0 Trials) |
|
| M267 / J&J (0 Trials) |
|
| M3541 / EMD Serono (0 Trials) |
|
| M4076 / EMD Serono (0 Trials) |
|
| M4112 / EMD Serono (0 Trials) |
|
| M4205 / EMD Serono (0 Trials) |
|
| M4645 / EMD Serono (0 Trials) |
|
| M4K2009 / M4K Pharma (0 Trials) |
|
| M4K2149 / M4K Pharma (0 Trials) |
|
| M5250 / Maruho (0 Trials) |
|
| M5717 / EMD Serono (0 Trials) |
|
| M610 / National Cancer Center Hospital (0 Trials) |
|
| M6123 / Ligand, EMD Serono (0 Trials) |
|
| M701 / CSPC Pharma (0 Trials) |
|
| M710 (aflibercept biosimilar) / J&J, Biocon (0 Trials) |
|
| M7583 / EMD Serono, Telios Pharma (1 Trials) |
|
| M802 / CSPC Pharma (0 Trials) |
|
| M834 (abatacept biosimilar) / Viatris (0 Trials) |
|
| M8891 / Cureteq, EMD Serono (0 Trials) |
|
| M9140 / EMD Serono (0 Trials) |
|
| M923 (adalimumab biosimilar) / J&J (0 Trials) |
|
| M9657 / EMD Serono (0 Trials) |
|
| M9831 / EMD Serono, Vertex (0 Trials) |
|
| MA-005 / Hofseth Biocare (0 Trials) |
|
| MA2-014 / Aptose Biosci (0 Trials) |
|
| Maalox (aluminum hydroxide/simethicone/magnesium hydroxide) / Sanofi (0 Trials) |
|
| MaaT013 / MaaT Pharma (0 Trials) |
|
| MaaT033 / MaaT Pharma (0 Trials) |
|
| MaaT03x / MaaT Pharma (0 Trials) |
|
| MAb-425 / Drexel University (0 Trials) |
|
| Maball (rituximab biosimilar) / Hetero (1 Trials) |
|
| mAbCo19 / AchilleS Vaccines (0 Trials) |
|
| MabionCD20 (rituximab biosimilar) / HB Human BioSci, Mabion (2 Trials) |
|
| MabionHER2 (trastuzumab biosimilar) / Mabion (0 Trials) |
|
| Mabtas (rituximab biosimilar) / Intas (1 Trials) |
|
| Mabura (adalimumab biosimilar) / Hetero (0 Trials) |
|
| Mabvinra (adalimumab biosimilar) / Alkem Labs (0 Trials) |
|
| mAbx01 (etanercept biosimilar) / Grupo Insud (0 Trials) |
|
| MACI (matrix-induced autologous chondrocyte implant) / Vericel (1 Trials) |
|
| macozinone (PBTZ169) / Innovative Medicines for Tuberculosis, Nearmedic, Bill & Melinda Gates Foundation (0 Trials) |
|
| Macrilen (macimorelin) / AEterna Zentaris, Novo Nordisk (3 Trials) |
|
| Macroazi (azithromycin) / Orchid (0 Trials) |
|
| macrocyclic peptide / Merck (MSD) (0 Trials) |
|
| macrolide analogs / Melinta Therap (0 Trials) |
|
| Macugen (pegaptanib) / Bausch Health (10 Trials) |
|
| Macuneos (BIO-201) / Biophytis (0 Trials) |
|
| MAD-bisphosphonate therapy / Navidea (0 Trials) |
|
| MAD-paclitaxel therapy / Navidea (0 Trials) |
|
| MAD0004J08 / Toscana Life Sci (0 Trials) |
|
| mafenide / Generic mfg. (0 Trials) |
|
| MAG200 / Magellan Biologicals (0 Trials) |
|
| MAGE A3 TCR / Gilead, National Cancer Institute (0 Trials) |
|
| MAGE-A4-specific TCR therapy / Medigene, 2seventy bio, Regeneron (0 Trials) |
|
| MageA1-TCR Gene Therapy of Multiple Myeloma / Medigene, Max Delbrück Centre for Molecular Medicine, Charite - University of Medicine Berlin (0 Trials) |
|
| Magicell-NK / Medigen Biotech (0 Trials) |
|
| Magna Effervescent (magnesium oxide+sodium carbonate+sodium bicarbonate+citric acid+saccharin sodium) / SEDICO (0 Trials) |
|
| magnesium L-lactate dehydrate (MLD10) / Pharmalyte Solutions (0 Trials) |
|
| magnesium trisilicate/dried aluminium hydroxide / Generic mfg. (0 Trials) |
|
| MagneVal (valproate magnesium) / BioLink Life Sci (0 Trials) |
|
| magrolimab (GS-4721) / Ono Pharma, Gilead (16 Trials) |
|
| MAHDL01 / World Health Energy, Mazal Plant Pharma (0 Trials) |
|
| MAIA-2021-20 / MAIA Biotech (0 Trials) |
|
| MAIA-2022-12 / MAIA Biotech (0 Trials) |
|
| MAK11049 / MAKScientific (0 Trials) |
|
| MAK1400 / Biogen (0 Trials) |
|
| MAK683 / Novartis (1 Trials) |
|
| MAL oral / D&A Pharma (0 Trials) |
|
| malaria vaccine / Sanofi (0 Trials) |
|
| malaria vaccine / Protein Potential, Chinook Therap (0 Trials) |
|
| malaria vaccine (Px533) / Ligand (0 Trials) |
|
| MALT1 protein inhibitor / Medivir (0 Trials) |
|
| MAM01/ATRC-501 / Atreca, Bill & Melinda Gates Foundation (0 Trials) |
|
| Mambisa (CIGB-669) / Center for Genetic Engineering and Biotechnology (0 Trials) |
|
| mammaglobin-A DNA vaccine / Washington University School of Medicine in St. Louis (0 Trials) |
|
| MAN-01 / Mannin Research, Q BioMed (0 Trials) |
|
| MAN-02 / Mannin Research, Q BioMed (0 Trials) |
|
| MAN-03 / Mannin Research, Q BioMed (0 Trials) |
|
| MAN-04 / Mannin Research, Q BioMed (0 Trials) |
|
| MAN-19 / Mannin Research, Q BioMed (0 Trials) |
|
| MANA-312 / MANA Therap (0 Trials) |
|
| MANA-412 / MANA Therap (0 Trials) |
|
| manelimab (BCD-135) / Biocad (0 Trials) |
|
| MANF / Healixa (0 Trials) |
|
| manfidokimab (AK120) / Akesobio (0 Trials) |
|
| ManNAc / Fortress, Leadiant Biosci (0 Trials) |
|
| mannoside FimH antagonist / Fimbrion Therap (0 Trials) |
|
| manocept-doxorubicin / Navidea (0 Trials) |
|
| MAP Kinase Kinase 2 inhibitors / Pfizer (0 Trials) |
|
| MAP-Tau based therapeutic / PTC Therap (0 Trials) |
|
| mapatumumab (HGS-ETR1) / GSK (0 Trials) |
|
| MAPK pathway therapeutic / Jazz, Redx (0 Trials) |
|
| mapracorat (BOL-303242-X) / Bayer (0 Trials) |
|
| maprotiline / Generic mfg. (1 Trials) |
|
| MAR701 / Roche (0 Trials) |
|
| Marabex (MAGE-A3 vaccine) / Turnstone Biologics, AbbVie (0 Trials) |
|
| maranmicin (ABX-605) / AGileBiotics (0 Trials) |
|
| Margenza (margetuximab) / MacroGenics, ZAI Lab (3 Trials) |
|
| Marinus / Aphios (0 Trials) |
|
| Marizev (omarigliptin) / Merck (MSD) (0 Trials) |
|
| marizomib (NPI-0052) / Triphase Accelerator Corporation, BMS (5 Trials) |
|
| Marplan (isocarboxazid) / Validus (0 Trials) |
|
| Marqibo (vincristine liposomal) / Servier, Aurobindo (6 Trials) |
|
| marrow infiltrating lymphocytes / WindMIL Therap (0 Trials) |
|
| marstacimab (PF-06741086) / Pfizer (2 Trials) |
|
| marzeptacog alfa (CB 813d) / GC Biopharma (0 Trials) |
|
| Marzulene-S Combination Granules / Kotobuki (0 Trials) |
|
| MAS1 modulator therapeutic / Omeros (0 Trials) |
|
| MAS825 / Novartis (0 Trials) |
|
| MASCT-I / HengRui YuanZheng (1 Trials) |
|
| masilukast (MCC-847) / Mitsubishi Tanabe (0 Trials) |
|
| masked antibody drug conjugate therapeutic / Adagene, Mitsubishi Tanabe (0 Trials) |
|
| masoprocol (TT-100) / TriAct Therap (0 Trials) |
|
| MASP-2 inhibitor therapeutic / Omeros (0 Trials) |
|
| MASP-2/3 inhibitor therapeutic / Omeros (0 Trials) |
|
| MASP-3 inhibitor therapeutic / Omeros (0 Trials) |
|
| masupirdine (SUVN-502) / Suven Life Sci (2 Trials) |
|
| Matulane (procarbazine hydrochloride) / Leadiant Biosci (16 Trials) |
|
| matuzumab (EMD 72000) / Takeda, EMD Serono (0 Trials) |
|
| MAU868 / Vera Therap (0 Trials) |
|
| mavatrep (JNJ-39439335) / J&J (0 Trials) |
|
| mavelertinib (PF-06747775) / Pfizer (0 Trials) |
|
| Mavenclad (cladribine) / EMD Serono (23 Trials) |
|
| maveropepimut-S (MVP-S) / IMV Inc (10 Trials) |
|
| mavoglurant (AFQ056) / Novartis (4 Trials) |
|
| mavorixafor (X4P-001) / X4 Pharma (5 Trials) |
|
| mavrilimumab (KPL-301) / Kiniksa (3 Trials) |
|
| MAVU-104 / AbbVie (0 Trials) |
|
| Mavyret (glecaprevir/pibrentasvir) / AbbVie, Enanta Pharma (30 Trials) |
|
| MAX-10129 / Maxinovel (0 Trials) |
|
| Max-10181 / Maxinovel (0 Trials) |
|
| Max-40279 / Maxinovel (3 Trials) |
|
| MAX-5 / Maxinovel (0 Trials) |
|
| MAX-6 / Maxinovel (0 Trials) |
|
| MAX-7 / Maxinovel (0 Trials) |
|
| Maxair autohaler (pirbuterol aerosol) / Bausch Health (0 Trials) |
|
| Maxidex (dexamethasone eye drops, suspension) / Novartis (17 Trials) |
|
| Maxido Plus (valsartan + hydrochlorothiazide) / Alvogen Korea (0 Trials) |
|
| Maxigesic (acetaminophen/ibuprofen) / AFT Pharma, Hyloris Pharma, BioSyent (0 Trials) |
|
| Maxomat (somatropin) / Sanofi (0 Trials) |
|
| Maxsulin (human insulin rDNA) / Incepta Pharma (0 Trials) |
|
| Maxy-G34 / Maxygen (0 Trials) |
|
| Mayzent (siponimod) / Novartis (11 Trials) |
|
| mazdutide (LY3305677) / Eli Lilly (0 Trials) |
|
| MazF gene therapy / Takara (0 Trials) |
|
| mazindol controlled release (NLS-2) / NLS Pharma (0 Trials) |
|
| MB-101 / Fortress (2 Trials) |
|
| MB-101 / Macrobian-Biotech (0 Trials) |
|
| MB-102 / Fortress (2 Trials) |
|
| MB-103 / Fortress (0 Trials) |
|
| MB-104 / Fortress (0 Trials) |
|
| MB-105 / Fortress (0 Trials) |
|
| MB-106 / Fortress (0 Trials) |
|
| MB-107 / Fortress (0 Trials) |
|
| MB-108 / Fortress (0 Trials) |
|
| MB-109 / Fortress (0 Trials) |
|
| MB-110 / Microbio (1 Trials) |
|
| MB-204 / Marvel Biosci (0 Trials) |
|
| MB-6 / Microbio (0 Trials) |
|
| MB-CAR-T19-22 / Miltenyi Biotec (0 Trials) |
|
| MB-CART 19.1 / Miltenyi Biotec (0 Trials) |
|
| MB-CART 2219.1 / Miltenyi Biotec (0 Trials) |
|
| MB-CART20.1 / Miltenyi Biotec (0 Trials) |
|
| MB-dNPM1-TCR.1 / Miltenyi Biotec (0 Trials) |
|
| MB-X01Y03 / Protheragen (0 Trials) |
|
| MB03 / Grupo Insud (0 Trials) |
|
| MB04 / Grupo Insud (0 Trials) |
|
| MB05 (palivizumab biosimilar) / Grupo Insud (0 Trials) |
|
| MB07133 / Xi’an XinTong Pharma (0 Trials) |
|
| MB09 (denosumab biosimilar) / Grupo Insud (0 Trials) |
|
| MB097 / Microbiotica (0 Trials) |
|
| MB11 / Grupo Insud (0 Trials) |
|
| MB12 (pembrolizumab biosimilar) / Grupo Insud (0 Trials) |
|
| MB13 / Grupo Insud (0 Trials) |
|
| MB1707 / Mainline Biosci (0 Trials) |
|
| MB310 / Microbiotica, Roche (0 Trials) |
|
| MB66 / Mapp Biopharma (0 Trials) |
|
| mbIL-15 TCR T-cell therapy / Alaunos Therap (0 Trials) |
|
| MBK-101 / Mablink Biosci (0 Trials) |
|
| MBK-102 / Mablink Biosci (0 Trials) |
|
| MBK-103 / Mablink Biosci (0 Trials) |
|
| MBL-HCV1 / MassBiologics (0 Trials) |
|
| MBL949 / Novartis (0 Trials) |
|
|